Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi

Abstract Background Mississippi (MS) has among the highest rates of cervical cancer incidence and mortality in the United States, with disproportionately higher rates among Blacks compared to Whites. Here, we evaluate the prevalence of high‐risk human papillomavirus (HPV) and abnormal cytology in a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Megan A. Clarke, Carolann Risley, Mary W. Stewart, Kim R. Geisinger, Laree M. Hiser, Jody C. Morgan, Kenyata J. Owens, Krishna Ayyalasomayajula, Rhonda M. Rives, Ashish Jannela, Dianne E. Grunes, Lei Zhang, Mark Schiffman, Sarah Wagner, Joseph Boland, Sara Bass, Nicolas Wentzensen
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/90411cc7167047ea9ce074f01ddcdbcc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90411cc7167047ea9ce074f01ddcdbcc
record_format dspace
spelling oai:doaj.org-article:90411cc7167047ea9ce074f01ddcdbcc2021-12-01T04:49:16ZAge‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi2045-763410.1002/cam4.4340https://doaj.org/article/90411cc7167047ea9ce074f01ddcdbcc2021-12-01T00:00:00Zhttps://doi.org/10.1002/cam4.4340https://doaj.org/toc/2045-7634Abstract Background Mississippi (MS) has among the highest rates of cervical cancer incidence and mortality in the United States, with disproportionately higher rates among Blacks compared to Whites. Here, we evaluate the prevalence of high‐risk human papillomavirus (HPV) and abnormal cytology in a representative baseline sample from a diverse statewide cohort of individuals attending cervical screening in MS from the STRIDES Study (STudying Risk to Improve DisparitiES in cervical cancer). Methods We included individuals aged 21–65 years undergoing screening at the University of Mississippi Medical Center (UMMC) and the Mississippi State Department of Health (MSDH) from May to November 2018. We calculated age‐specific HPV prevalence, overall and by partial HPV16/18 genotyping, and abnormal cytology by race. Results A total of 6871 individuals (mean age 35.7 years) were included. HPV prevalence was 25.6% and higher in Blacks (28.0%) compared to Whites (22.4%). HPV prevalence was significantly higher in Blacks aged 21–24 years (50.2%) and 30–34 years (30.2%) compared to Whites in the same age groups (32.1% and 20.7%; p < 0.0001, respectively). The prevalence of high‐grade cytologic abnormalities, a cytologic sign of cervical precancer, peaked earlier in Blacks (ages 25–29) compared to Whites (35–39). For comparison, we also analyzed HPV prevalence data from the National Health and Nutrition Examination Survey (NHANES, 2013–2016) and observed similar racial differences in HPV prevalence among women aged 21–24 years. Conclusions Our findings suggest that Blacks undergoing cervical cancer screening in MS have higher prevalence of other high‐risk 12 HPV types at younger ages and experience an earlier peak of high‐grade cytologic abnormalities compared to Whites.Megan A. ClarkeCarolann RisleyMary W. StewartKim R. GeisingerLaree M. HiserJody C. MorganKenyata J. OwensKrishna AyyalasomayajulaRhonda M. RivesAshish JannelaDianne E. GrunesLei ZhangMark SchiffmanSarah WagnerJoseph BolandSara BassNicolas WentzensenWileyarticlecervical cancerhuman papillomavirusMississippinatural historyracial differencesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Medicine, Vol 10, Iss 23, Pp 8641-8650 (2021)
institution DOAJ
collection DOAJ
language EN
topic cervical cancer
human papillomavirus
Mississippi
natural history
racial differences
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle cervical cancer
human papillomavirus
Mississippi
natural history
racial differences
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Megan A. Clarke
Carolann Risley
Mary W. Stewart
Kim R. Geisinger
Laree M. Hiser
Jody C. Morgan
Kenyata J. Owens
Krishna Ayyalasomayajula
Rhonda M. Rives
Ashish Jannela
Dianne E. Grunes
Lei Zhang
Mark Schiffman
Sarah Wagner
Joseph Boland
Sara Bass
Nicolas Wentzensen
Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
description Abstract Background Mississippi (MS) has among the highest rates of cervical cancer incidence and mortality in the United States, with disproportionately higher rates among Blacks compared to Whites. Here, we evaluate the prevalence of high‐risk human papillomavirus (HPV) and abnormal cytology in a representative baseline sample from a diverse statewide cohort of individuals attending cervical screening in MS from the STRIDES Study (STudying Risk to Improve DisparitiES in cervical cancer). Methods We included individuals aged 21–65 years undergoing screening at the University of Mississippi Medical Center (UMMC) and the Mississippi State Department of Health (MSDH) from May to November 2018. We calculated age‐specific HPV prevalence, overall and by partial HPV16/18 genotyping, and abnormal cytology by race. Results A total of 6871 individuals (mean age 35.7 years) were included. HPV prevalence was 25.6% and higher in Blacks (28.0%) compared to Whites (22.4%). HPV prevalence was significantly higher in Blacks aged 21–24 years (50.2%) and 30–34 years (30.2%) compared to Whites in the same age groups (32.1% and 20.7%; p < 0.0001, respectively). The prevalence of high‐grade cytologic abnormalities, a cytologic sign of cervical precancer, peaked earlier in Blacks (ages 25–29) compared to Whites (35–39). For comparison, we also analyzed HPV prevalence data from the National Health and Nutrition Examination Survey (NHANES, 2013–2016) and observed similar racial differences in HPV prevalence among women aged 21–24 years. Conclusions Our findings suggest that Blacks undergoing cervical cancer screening in MS have higher prevalence of other high‐risk 12 HPV types at younger ages and experience an earlier peak of high‐grade cytologic abnormalities compared to Whites.
format article
author Megan A. Clarke
Carolann Risley
Mary W. Stewart
Kim R. Geisinger
Laree M. Hiser
Jody C. Morgan
Kenyata J. Owens
Krishna Ayyalasomayajula
Rhonda M. Rives
Ashish Jannela
Dianne E. Grunes
Lei Zhang
Mark Schiffman
Sarah Wagner
Joseph Boland
Sara Bass
Nicolas Wentzensen
author_facet Megan A. Clarke
Carolann Risley
Mary W. Stewart
Kim R. Geisinger
Laree M. Hiser
Jody C. Morgan
Kenyata J. Owens
Krishna Ayyalasomayajula
Rhonda M. Rives
Ashish Jannela
Dianne E. Grunes
Lei Zhang
Mark Schiffman
Sarah Wagner
Joseph Boland
Sara Bass
Nicolas Wentzensen
author_sort Megan A. Clarke
title Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
title_short Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
title_full Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
title_fullStr Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
title_full_unstemmed Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
title_sort age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in mississippi
publisher Wiley
publishDate 2021
url https://doaj.org/article/90411cc7167047ea9ce074f01ddcdbcc
work_keys_str_mv AT meganaclarke agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT carolannrisley agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT marywstewart agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT kimrgeisinger agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT lareemhiser agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT jodycmorgan agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT kenyatajowens agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT krishnaayyalasomayajula agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT rhondamrives agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT ashishjannela agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT dianneegrunes agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT leizhang agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT markschiffman agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT sarahwagner agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT josephboland agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT sarabass agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
AT nicolaswentzensen agespecificprevalenceofhumanpapillomavirusandabnormalcytologyatbaselineinadiversestatewideprospectivecohortofindividualsundergoingcervicalcancerscreeninginmississippi
_version_ 1718405736466219008